Longeveron Inc - Class A (LGVN) Company Profile & Statistics

Longeveron Inc - Class A
LGVN
(Nasdaq - US)
N/A
1.52
-0.14 (-8.43%)
in:usd•As of: May 09, 2024 15:27 UTC -4
Open
1.65
High
1.65
Low
1.52

About Longeveron Inc - Class A

CEO

Mohamed Wa¿el Ahmed Hashad

Headquarters

1951 nw 7th avenue, suite 520

miami, fl 33136, united states

Auditor

Marcum llp

Employees

Share Holders

Website

https://longeveron.com

Industry

biotechnology

Sector

health technology

Company Overview

Longeveron Inc. is a clinical stage biotechnology company. It engages in developing cellular therapies for chronic aging-related and life-threatening conditions. The company's investigational product includes LOMECEL-B(TM). Longeveron Inc. is based in MIAMI.

Longeveron Inc - Class A Statistics

Valuation Measures

Market Capitalization ²	4.22M
Enterprise Value	719.00K
Enterprise Value/EBITDA (ttm)	-0.04
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.63
Price to Sales (ttm)	5.96
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	25.73%
Operating Margin (ttm)	-3020.17%
Profit Margin (ttm)	-4441.31%
Return on Equity (ttm)	-209.14%
Return on Invested Capital (ttm)	-229.08%
Return on Assets (ttm)	-136.82%

Income Statement

Revenue (ttm)	709.00K
Revenue Per Share (ttm)	0.28
Gross Profit (ttm)	221.00K
EBITDA (ttm)³	-20.08M
Net Income Avi to Common (ttm)	-22.21M
Diluted EPS (ttm)	-10.20

Share Statistics

Beta (5Y Monthly)	0.51
52-Week Change	-96.20%
S&P500 52-Week Change	26.49%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	2.51M
Dividend Yield	0.00%
Float ⁴	1.90M
% Held by Insiders	24.34%
% Held by Institutions	10.01%

Balance Sheet

Total Cash (mrq)	5.36M
Total Cash Per Share (mrq)	2.13
Total Debt (mrq)	1.45M
Total Debt/Equity (mrq)	21.48%
Current Ratio (mrq)	1.50%
Quick Ratio (mrq)	1.50%
Book Value Per Share (mrq)	2.68

Cash Flow

Operating Cash Flow Per Share (ytd)	-8.74
Free Cash Flow (ytd)	-19.30M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Longeveron Inc - Class A

Trade With A Regulated Broker